Mission Therapeutics and AbbVie team up to develop DUB inhibitors to treat Alzheimer’s and Parkinson’s Diseases

Mission Therapeutics (“Mission”), a drug creator company focused on selectively […]
read more »Mission Therapeutics (“Mission”), a drug creator company focused on selectively […]
read more »On Wednesday, Alector, a startup that focuses on developing new […]
read more »